Leading life sciences organizations are increasingly leveraging AI and automation across the end-to-end pharmacovigilance (PV) lifecycle, utilizing the latest technologies and strategies to innovate how they work in months, not years, and see real-world value in just weeks.
In this blog , we outline what these organizations are prioritizing when evaluating solutions and finding the right partner that can support their unique digital transformation goals.
It’s Time to Embrace an AI-Forward Approach
Amid skyrocketing case volumes and ever-growing global footprints, PV teams are under immense pressure to keep their operations lean, save time and money, and ensure patient safety, all while navigating complex regulatory landscapes.
Advancements in AI and automation provide a unique opportunity to these PV teams, helping them overcome these challenges, alongside generating significant time savings, cost-efficient scalability, and enhanced patient outcomes.
Although the benefits of an AI-driven approach are evident, implementing it across the entire pharmacovigilance lifecycle and global operations can be overwhelming, often requiring extensive, complex deployments that delay time-to-value and increase costs.
This is where operationalizing AI and automation in PV comes in.
Why Organizations are Investing in End-to-End PV AI Operationalization
Leading organizartions are making proactive investments to ensure that their PV teams get the most out of the latest innovations in a timely manner with minimal overhead. This includes:
- Expedited Deployment – Avoiding lengthy and costly implementations by selecting more streamlined and cost-efficient deployment processes.
- Accelerated Time-to-Value – Ensuring time and cost savings from their AI investments now – not just in the distant future.
- Real-World Results – Going beyond AI and automation pilots to real-world applications that deliver measurable value today.
By making these investments, these organizations are realizing unmatched value across their end-to-end PV workflows, including up to:
- 65% efficiency gains in PV case intake.
- 70% faster processing in medical literature intake.
- 50% faster field case reporting.
- 80% efficiency gains in MedDRA coding.
- 70% faster medical drafting and content generation.
- 80% faster case assessment in signal detection.
What to Look for in a PV Automation Partner
Safety automation partners vary widely in what they offer, and so it is essential to choose those best equipped to align with your strategic objectives and deliver measurable impact.
Below are some critical criteria leading orgnanizations are prioritizing when evaluating solutions and providers:
- Cutting-Edge Innovation – Ensure your provider actively invests in the latest AI and automation, including GenAI and Agentic AI capabilities.
- Built by PV, for PV – Choose solutions built on extensive domain experience by a provider with the knowledge to help you achieve your unique, PV-specific goals.
- End-to-End Coverage – Prioritize solutions that bring AI and automation into every step of the PV lifecycle, from case intake and processing to signal detection.
- Flexibility and Scalability – Remain future-ready with a platform that can grow as you do, tailorable to wherever you are on your automation journey.
- Proven Results – Make sure you leverage PV AI and automation that is production-ready and has delivered value across numerous real-world deployments.
- Business Transformation – Work with PV experts that help you maximize value and ensure seamless business continuity through the solution adoption lifecycle.
Don’t Wait – Get the Most Out of AI in PV Today
Ready to take the next step? LifeSphere Safety offers industry-leading end-to-end AI and automation for PV via a rapidly deployable platform, globally known for delivering measurable results today for top pharma.
See why leading life sciences organizations are choosing ArisGlobal as their Safety automation partner and how you can get the most out of AI in PV today.
